The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Axcella Health Inc | COM | 05454B105 | 25,661 | 12,640,890 | SH | DFND | 2,3 | 0 | 12,640,890 | 0 | |
Axcella Health Inc | COM | 05454B105 | 9,066 | 4,465,866 | SH | DFND | 3,4 | 0 | 4,465,866 | 0 | |
Axcella Health Inc | COM | 05454B105 | 3,575 | 1,761,029 | SH | DFND | 3 | 0 | 1,761,029 | 0 | |
Codiak Biosciences Inc | COM | 192010106 | 6,110 | 2,121,354 | SH | DFND | 1,3 | 0 | 2,121,354 | 0 | |
Codiak Biosciences Inc | COM | 192010106 | 1,400 | 485,949 | SH | DFND | 3 | 0 | 485,949 | 0 | |
Denali Therapeutics Inc | COM | 24823R105 | 77,106 | 2,619,968 | SH | DFND | 1,3 | 0 | 2,619,968 | 0 | |
Evelo Biosciences Inc | COM | 299734103 | 21,443 | 10,205,282 | SH | DFND | 1,3 | 0 | 10,205,282 | 0 | |
Evelo Biosciences Inc | COM | 299734103 | 21,533 | 10,162,664 | SH | DFND | 2,3 | 0 | 10,162,664 | 0 | |
Evelo Biosciences Inc | COM | 299734103 | 11,595 | 5,495,324 | SH | DFND | 3,4 | 0 | 5,495,324 | 0 | |
Evelo Biosciences Inc | COM | 299734103 | 17,344 | 8,219,791 | SH | DFND | 3,6 | 0 | 8,219,791 | 0 | |
Evelo Biosciences Inc | COM | 299734103 | 34,486 | 16,344,267 | SH | DFND | 3 | 0 | 16,344,267 | 0 | |
Foghorn Therapeutics Inc | COM | 344174107 | 126,900 | 9,330,878 | SH | DFND | 1,3 | 0 | 9,330,878 | 0 | |
Foghorn Therapeutics Inc | COM | 344174107 | 20,284 | 1,491,441 | SH | DFND | 3,4 | 0 | 1,491,441 | 0 | |
Foghorn Therapeutics Inc | COM | 344174107 | 25,184 | 1,851,801 | SH | DFND | 3,5 | 0 | 1,851,801 | 0 | |
Moderna Inc | COM | 60770K107 | 1,840,311 | 12,882,819 | SH | DFND | 2,3 | 0 | 12,882,819 | 0 | |
Moderna Inc | COM | 60770K107 | 561 | 3,924 | SH | DFND | 3 | 0 | 3,924 | 0 | |
Omega Therapeutics Inc | COM | 68217N105 | 26,542 | 6,984,856 | SH | DFND | 1,3 | 0 | 6,984,856 | 0 | |
Omega Therapeutics Inc | COM | 68217N105 | 20,956 | 5,514,707 | SH | DFND | 3,5 | 0 | 5,514,707 | 0 | |
Omega Therapeutics Inc | COM | 68217N105 | 3,688 | 970,588 | SH | DFND | 3,6 | 0 | 970,588 | 0 | |
Omega Therapeutics Inc | COM | 68217N105 | 32,746 | 8,617,413 | SH | DFND | 3,7 | 0 | 8,617,413 | 0 | |
Omega Therapeutics Inc | COM | 68217N105 | 14,496 | 3,814,705 | SH | DFND | 3 | 0 | 3,814,705 | 0 | |
Rubius Therapeutics Inc | COM | 78116T103 | 9,902 | 11,648,828 | SH | DFND | 1,3 | 0 | 11,648,828 | 0 | |
Rubius Therapeutics Inc | COM | 78116T103 | 20,590 | 24,223,995 | SH | DFND | 2,3 | 0 | 24,223,995 | 0 | |
Rubius Therapeutics Inc | COM | 78116T103 | 2,239 | 2,633,703 | SH | DFND | 3,4 | 0 | 2,633,703 | 0 | |
Sana Biotechnology Inc | COM | 799566104 | 84,057 | 13,072,570 | SH | DFND | 1,3 | 0 | 13,072,570 | 0 | |
Sana Biotechnology Inc | COM | 799566104 | 62,533 | 9,725,122 | SH | DFND | 3,7 | 0 | 9,725,122 | 0 | |
Sana Biotechnology Inc | COM | 799566104 | 73,568 | 11,441,326 | SH | DFND | 3 | 0 | 11,441,326 | 0 | |
Seres Therapeutics Inc | COM | 81750R102 | 28,993 | 8,452,876 | SH | DFND | 2,3 | 0 | 8,452,876 | 0 | |
Seres Therapeutics Inc | COM | 81750R102 | 10,163 | 2,962,963 | SH | DFND | 3,7 | 0 | 2,962,963 | 0 | |
Seres Therapeutics Inc | COM | 81750R102 | 10,163 | 2,962,963 | SH | DFND | 3,6 | 0 | 2,962,963 | 0 | |
Sigilon Therapeutics Inc | COM | 82657L107 | 7,378 | 8,888,888 | SH | DFND | 1,3 | 0 | 8,888,888 | 0 | |
Sigilon Therapeutics Inc | COM | 82657L107 | 1,230 | 1,481,481 | SH | DFND | 3,5 | 0 | 1,481,481 | 0 | |
Syros Pharmaceuticals Inc | COM | 87184Q107 | 2,821 | 2,938,494 | SH | DFND | 2,3 | 0 | 2,938,494 | 0 |